Can a fixed dose of immune cells make stem cell transplants safer?
NCT ID NCT00959140
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study looks at whether giving a set number of immune cells (CD3+ T cells) during a stem cell transplant from a sibling donor leads to more predictable results and fewer complications. About 20 adults will receive a fixed dose of these cells. The goal is to see if this approach reduces the severity of graft-versus-host disease and makes recovery easier to manage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama Hospital
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.